Skip to content
Post Test and Evaluation
Please note that to receive credit you must achieve a score of at least 70%.
Credit will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity.
Post-Activity Test
1.
The therapeutic target of epoprostenal is within the:
(Required.)
Endothelin pathway
Prostacyclin pathway
Glutathione pathway
Nitric oxide pathway
2.
Treprostinil is available in all of the following formulations except:
(Required.)
Oral
Intravenous
Subcutaneous
Inhaled
3.
The use of nitrates is contraindicated in patients receiving a phosphodiesterase type 5 (PDE-5) inhibitor.
(Required.)
True
False
4.
Pulmonary arterial hypertension is defined as having a mean pulmonary arterial pressure (mPAP) of:
(Required.)
>10 mmHg
>25 mmHg
>40 mmHg
>60 mmHg
5.
Current PAH therapy targets all of the following pathways except:
(Required.)
Vasoactive intestinal peptide (VIP)
Endothelin
Nitric Oxide
Prostacyclin